By Dr Vivek Narisetty, of Bedford-based clean-tech company, C-Source Renewables Limited.
As the UK accelerates toward a more resource-efficient and low-carbon economy, much of the conversation around the circular bioeconomy has focused on technology.
From advanced biorefinery platforms to waste-to-resource conversion processes, innovation in this space has progressed rapidly. Yet as these technologies move closer to commercialisation, a less visible, but equally critical, constraint is emerging: access to specialist scientific talent.
The transition from fossil-based systems to bio-based manufacturing is not just a technological shift. It represents a fundamental change in how raw materials are sourced, processed, and integrated into existing industrial frameworks. At the heart of this transformation lies a complex interplay between chemistry, microbiology, and engineering – disciplines that must work together to deliver viable, scalable solutions.
As a result, companies operating within the circular bioeconomy are increasingly competing not just on innovation, but on expertise.
There is a growing demand for scientists with deep knowledge of biomass conversion, biorefinery systems, and microbial processes – in short, individuals capable of translating laboratory research into industrial applications. While significant progress has been made in converting waste-derived feedstocks into fermentable sugars and platform chemicals, the challenge of scaling these processes remains substantial.
Laboratory environments allow for tightly controlled conditions and consistent inputs. In contrast, industrial settings introduce variability at every stage, from feedstock composition to process efficiency and cost constraints. Bridging this gap requires far more than technical understanding; it demands experience in how biological and chemical systems perform under real-world conditions.
This is where specialist expertise becomes commercially critical.
“The science itself is only part of the equation,” explains Dr Vivek Narisetty. “The real challenge lies in ensuring that what works in a controlled lab environment can be translated into a process that is robust, scalable, and economically viable in industry.
“That requires a deep understanding of both the fundamentals and the practical limitations of bioprocess systems.”
Dr Narisetty’s work spans the conversion of both first- and second-generation feedstocks into value-added products, including a range of value-added products diols, alcohols, sugar alcohols, organic acids, food & feed grade proteins, microbial lipids, and other bulk and speciality metabolites – areas that are increasingly central to the development of bio-based alternatives across multiple industries.
His experience reflects a broader shift within the sector, where interdisciplinary expertise is becoming essential to progress.
For industries transitioning toward bio-based feedstocks, whether in chemicals, materials, or consumer products, the implications are significant. Adopting alternative inputs is not a simple substitution.
It requires the redesign of processes, adaptation of supply chains, and, in many cases, the re-evaluation of product specifications. Without the right expertise in place, even the most promising technologies can struggle to move beyond pilot stages.
This has led to a growing emphasis on building multidisciplinary teams capable of addressing these challenges holistically.
Companies at the forefront of the circular bioeconomy are increasingly integrating expertise across microbiology, chemical engineering, and process development to bridge the gap between concept and commercialisation. This reflects a growing understanding that no single discipline can solve the complexities of waste-to-resource systems in isolation.
At organisations such as ours, this model is already being applied in practice. By focusing on the conversion of industrial starchy waste streams and lignocellulosic biomass into fermentable sugars, the company operates at the intersection of scientific precision and industrial practicality.
The development of such processes depends heavily on optimising yields, managing variability, and ensuring consistency at scale – all areas where specialist knowledge is indispensable.
More broadly, this shift highlights a critical consideration for the UK’s bioeconomy ambitions: the need to retain and effectively deploy scientific talent.
The UK benefits from a strong research base, supported by world-class universities and innovation programmes.
However, ensuring that this expertise translates into industrial capability will be key to maintaining competitiveness on a global stage. Without clear pathways for scientists to move between academia and industry, valuable knowledge risks remaining underutilised.
Encouraging greater collaboration between research institutions and commercial organisations will be essential. Equally important is creating environments where scientists can apply their expertise to real-world challenges, contributing not only to technological advancement but to the development of commercially viable solutions.
“The future of the bioeconomy will depend on how effectively we can connect research with application,” adds Dr Narisetty. “It’s about taking fundamental science and shaping it into processes that industry can adopt at scale, reliably and efficiently.”
Ultimately, while innovation provides the tools, it is scientific expertise that will determine how effectively they are applied. As the circular bioeconomy continues to evolve, talent is no longer a supporting factor – it is a defining one.
